Loading…
Based on limited metadata, Contacare Ophthalmics & Diagnostics, a pharmaceutical company, received an FDA Warning Letter on April 23, 2019, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the compliance violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory jurisdiction, though the specific issuing office and detailed violation count are not documented in this metadata summary.